Insulin resistance, defined as a defect in insulin-mediated control of glucose metabolism in tissues such as liver, fat and muscle, is a significant contributor to the development of type 2 diabetes mellitus (T2DM) and cardiovascular disease, particularly in the context of obesity and metabolic syndrome (1–3). Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.